EVERESTO logo

Everest Organics Ltd

EVERESTO·BSE·
272.55 +0.65 (+0.24%)
Market Cap259.32 Cr
PE Ratio55.60
Volume2,799
Day High - Low284.00 - 267.00
52W High-Low536.40 - 197.00
DocStoX Score
0.7/10
Poor
Fair Value
Sign in to see
ROE
7.63%
Weak
P/E
55.60x
Expensive
Debt / Equity
0.66
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day267.00
284.00
52W197.00
536.40
DocStoX take

Held back by valuation (0.0).

DocStoX score

Low confidence
0.7
/10
Poor
Quality
Weak
ROE 7.6%
Valuation
Expensive
P/E 55.6×
Growth
Flat
Revenue +1.5% 5Y CAGR
Risk
Elevated
D/E 0.66
Momentum
Weak
22% of 52-week range

At a glance

Market Cap
₹259 Cr
52W High / Low
₹536 / ₹197
Dividend Yield
0.17%
Promoter Holding
59.60%
EPS (TTM)
₹4.90
Book Value
₹79.69

Key highlights

  • Profit shrinking 16% a year
  • Loss-making in some of the last 5 years
0 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Everest Organics Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.